It also revealed that the antitumor effect of anlotinib was mainly via inhibition of VEGFR2 phosphorylation levels and the subsequent effects on activation of the PIK3/AKT signal to cause changes in proliferation, apoptosis, and invasion of tumor cells. The gene discussed is AKT1; the disease is neoplasm.